Phathom Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript
Good morning, everyone. Thank you for joining the 21st Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Phathom Pharmaceuticals.
Joining us today from Phathom is President and CEO, Terrie Curran; COO, Azmi Nabulsi; Chief Commercial Officer, Martin Gilligan; Tom Harris, Head of Regulatory Affairs; and the CFO, Molly Henderson.
For those of you joining on the webcast, if you want to ask a question, please do so at any time. You can submit a question using the chat box at the bottom of your screen. With that, we'll get started.
I'll turn it over to Terrie for opening remarks, and then we'll start the chat.
Hi, Joey, and thanks for inviting us to the conference today. Phathom is a company that was formed around an asset called vonoprazan, which is a potassium-competitive acid blocker,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
